指南与共识衰弱、肌少症与跌倒老年综合评估

肌少症概念定义:GLIS德尔菲共识

The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS).
指南 / 共识 · Age Ageing · 2024-01-01

国际肌少症全球领导力倡议(GLIS)通过两阶段国际德尔菲研究,邀请29国107名专家对肌少症定义相关陈述进行共识投票。结果确认肌肉量、肌力和肌肉特异性力量为肌少症组成部分,而躯体功能受损为结局而非组成部分,形成首个全球肌少症概念定义。

要点

  • 肌少症概念定义包含肌肉量、肌力和肌肉特异性力量三个组成部分。
  • 躯体功能受损被认定为肌少症结局,而非其组成部分。
  • 该概念定义将用于制定临床和研究中的操作性定义。

核心结论

  • GLIS建立了首个全球肌少症概念定义,将肌肉量、肌力和肌肉特异性力量纳入定义组成部分,躯体功能受损作为结局。

研究设计与样本

  • GLIS指导委员会于2019-21年成立,由全球相关科学学会代表组成,随后邀请学会成员参与两阶段国际德尔菲研究。
  • 2022至2023年间,参与者使用在线调查工具(SurveyMonkey)对陈述进行同意度排序。

主要发现

  • 107名参与者(平均年龄54±12岁,64%为男性)来自7大洲/区域的29个国家完成了德尔菲调查。
  • 20条陈述获得强共识,包括6条关于肌少症一般方面、3条关于组成部分和11条关于结局。
  • 强共识中最强同意:肌少症患病率随年龄增长而增加(98.3%)。
  • 肌肉量(89.4%)、肌力(93.1%)和肌肉特异性力量(80.8%)均应纳入肌少症概念定义。
  • 强共识中最强同意:肌少症增加躯体功能受损风险(97.9%)。

关键数值与推荐

  • 陈述分类基于预设阈值:强共识(>80%)、中度共识(70-80%)和低共识(<70%)。
  • 强共识陈述被接受,低共识陈述被拒绝,中度共识陈述重新引入直至达成共识。

临床怎么用

  • 临床中评估肌少症应关注肌肉量、肌力和肌肉特异性力量,并将躯体功能受损视为结局。
  • 该概念定义将用于制定肌少症的操作性定义,服务于临床和研究场景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Sarcopenia, the age-related loss of muscle mass and strength/function, is an important clinical condition. However, no international consensus on the definition exists. OBJECTIVE: The Global Leadership Initiative in Sarcopenia (GLIS) aimed to address this by establishing the global conceptual definition of sarcopenia. DESIGN: The GLIS steering committee was formed in 2019-21 with representatives from all relevant scientific societies worldwide. During this time, the steering committee developed a set of statements on the topic and invited members from these societies to participate in a two-phase International Delphi Study. Between 2022 and 2023, participants ranked their agreement with a set of statements using an online survey tool (SurveyMonkey). Statements were categorised based on predefined thresholds: strong agreement (>80%), moderate agreement (70-80%) and low agreement (<70%). Statements with strong agreement were accepted, statements with low agreement were rejected and those with moderate agreement were reintroduced until consensus was reached. RESULTS: 107 participants (mean age: 54 ± 12 years [1 missing age], 64% men) from 29 countries across 7 continents/regions completed the Delphi survey. Twenty statements were found to have a strong agreement. These included; 6 statements on 'general aspects of sarcopenia' (strongest agreement: the prevalence of sarcopenia increases with age (98.3%)), 3 statements on 'components of sarcopenia' (muscle mass (89.4%), muscle strength (93.1%) and muscle-specific strength (80.8%) should all be a part of the conceptual definition of sarcopenia)) and 11 statements on 'outcomes of sarcopenia' (strongest agreement: sarcopenia increases the risk of impaired physical performance (97.9%)). A key finding of the Delphi survey was that muscle mass, muscle strength and muscle-specific strength were all accepted as 'components of sarcopenia', whereas impaired physical performance was accepted as an 'outcome' rather than a 'component' of sarcopenia. CONCLUSION AND RELEVANCE: The GLIS has created the first global conceptual definition of sarcopenia, which will now serve to develop an operational definition for clinical and research settings.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Kirk B, Cawthon PM, Arai H, et al. The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing. 2024. PMID: 38520141. doi:10.1093/ageing/afae052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。